ABCL
AbCellera Biologics (ABCL) Investor Questions
Review AbCellera Biologics (ABCL) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- AbCellera Biologics
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 70
- Annual revenue
- $75.13M
- Annual net income
- $-146.41M
- Annual free cash flow
- $-174.07M
AbCellera Biologics (ABCL) Investor Questions research
AbCellera Biologics trades under the ticker ABCL. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review ABCL through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.